TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient outcomes, has signed a definitive agreement to acquire Seisa Medical in a deal that significantly extends TekniPlex Healthcare’s medical technology solutions platform. This acquisition specifically enhances the company’s materials science and process technologies for minimally invasive and interventional therapy devices on a global scale.
Based in El Paso, Texas, Seisa is a medical device manufacturer servicing every stage of the product life cycle including design and development, component manufacturing, and final assembly. It employs more than 2,000 people across four facilities in the U.S., Mexico and Slovakia.
“This is a transformative acquisition for TekniPlex Healthcare, moving us squarely into the CDMO (contract, development, and manufacturing organization) segment of MedTech for medical technologies,” said Chris Qualters, CEO of TekniPlex Healthcare. “The ability for us to engage with our global customers on new medical technologies by developing engineered materials, co-designing components and assemblies, utilizing advanced process technologies and providing sterile barrier products allows us to truly partner with them from concept all the way to the point of care to help improve patient outcomes.
“Medical technologies are rapidly evolving to support more minimally invasive procedures and efficient interventional therapies,” said Bryan Wesselmann, Vice President of Sales and Marketing for TekniPlex Healthcare. “Seisa brings broad capabilities to advance these interventional technologies such as AAA (abdominal aortic aneurysms) stent grafts, thoracic endovascular grafts, mitral heart valves, endovascular procedures and cardiovascular catheter delivery systems.”
Julio Chiu, Seisa founder and CEO, said “our customers count on us to deliver solutions for their most challenging applications. I am very confident that they will continue to count on us as TekniPlex Healthcare shares our same commitment to deliver better patient outcomes. We believe the combination of our two organizations will result in one of the most comprehensive value-added CDMO platforms in the industry.”
This is the 20th acquisition that TekniPlex has completed in the past decade, supporting its strategy to grow its business through transformative acquisitions and strategic add-ons. The closing of the acquisition is conditioned upon regulatory approval.
